# FDA recall D-0002-2015

> **Hospira Inc.** · Class I · drug recall initiated 2014-06-17.

## Product

Marcaine (bupivacaine HCl) injection, USP, 0.5%, Preservative-Free, 30 mL (150 mg) Single-dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045   NDC 0409-1560-29

## Reason for recall

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0002-2015
- **Recalling firm:** Hospira Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-06-17
- **Report date:** 2014-10-08
- **Termination date:** 2017-04-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0002-2015

## Citation

> AI Analytics. FDA recall D-0002-2015. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0002-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*